An HPLC tracing of the enhancer regulation in selected discrete brain areas of food-deprived rats

Life Sciences

Volumn 72, Issue 25, 2003, Pages 2923-2930

  Miklya, I ^a   Knoll, B ^a   Knoll, J ^b  

^a INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^b SEMMELWEIS UNIVERSITY   (Hungary)

Author keywords

Catecholaminergic serotonergic activity in the brain stem; Enhancer regulation; Food deprivation; Hunger drive; Locus coeruleus; Norepinephrine dopamine serotonin release from striatum; Raphe; Substantia nigra; Tuberculum olfactorium

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BRAIN; CATECHOLAMINE NERVE CELL; CONTROLLED STUDY; CORPUS STRIATUM; DOPAMINE RELEASE; ELECTROCHEMISTRY; FOOD DEPRIVATION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; LOCUS CERULEUS; MALE; NERVE EXCITABILITY; NEUROTRANSMITTER RELEASE; NONHUMAN; NORADRENALIN RELEASE; OLFACTORY NUCLEUS; RAPHE NUCLEUS; RAT; SEROTONIN RELEASE; SEROTONINERGIC NERVE CELL; SUBSTANTIA NIGRA; VALIDATION PROCESS;

MAMMALIA;

EID: 0037427373     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(03)00192-9     Document Type: Article

References (12)

1. Knoll J. Experimental studies on the higher nervous activity of animals. VI. Further studies on active reflexes. Acta Physiologica Academiae Scientiarum Hungaricae. 12:1957;65-92.
2. Knoll J. The theory of active reflexes. An analysis of some fundamental mechanisms of higher nervous activity. Publishing House of the Hungarian Academy of Sciences, Budapest, New York: Hafner Publishing Company; 1969. p. 1-131.
3. Knoll J. Memories of my 45 years in research. Pharmacology and Toxicology. 75:1994;65-72.
4. Knoll J. Antiaging compounds: (-)Deprenyl (Selegiline) and (-)-(benzofuran-2-yl)-2-propylaminopentane, (-)BPAP, a selective highly potent enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. CNS Drug Reviews. 7:2001;317-345.
5. Knoll J., Miklya I. Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity. Rationale for prophylactic (-)deprenyl (selegiline) medication. Life Sciences. 56:1995;611-620.
6. Knoll J., Miklya I., Knoll B., Markó R., Kelemen K. (-)Deprenyl and (-)1- phenyl-2-propylaminopentane, [(-)PPAP], act primarily as potent stimulants of action potential-transmitter release coupling in the catecholaminergic neurons. Life Sciences. 58:1996;817-827.
7. Knoll J., Miklya I., Knoll B., Markó R., Rácz D. Phenylethylamine and tyramine are mixed-acting sympathomimetic amines in the brain. Life Sciences. 58:1996;2101-2114.
8. Knoll J., Yoneda F., Knoll B., Ohde H., Miklya I. (-)1-(Benzofuran-2-yl)-2-propylaminopentane, (-)BPAP, a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. British Journal of Pharmacology. 128:1999;1723-1732.
9. Knoll J., Miklya I., Knoll B. Stimulation of the catecholaminergic and serotoninergic neurons in the rat brain by R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane, (-)-BPAP. Life Sciences. 71:2002;2137-2144.
10. Knoll J., Miklya I., Knoll B., Yasusa T., Shimazu S., Yoneda F. 1-(Benzofuran-2-yl)-2-(3,3,3-trifluoropropyl)aminopentane HCl, 3-F-BPAP, antagonizes the enhancer effect of (-)-BPAP in the shuttle box and leaves the effect of (-)-deprenyl unchanged. Life Sciences. 71:2002;1975-1984.
11. Shimazu S., Takahata K., Katsuki H., Tsunekawa H., Tanigawa A., Yoneda F., Knoll J., Akaike A. (-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release. European Journal of Pharmacology. 421:2001;181-189.
12. Yoneda F., Moto T., Sakae M., Ohde H., Knoll B., Miklya I., Knoll J. Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, (-)BPAP, a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain. Bioorganic and Medicinal Chemistry. 9:2001;1197-1212.